These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy. Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279 [TBL] [Abstract][Full Text] [Related]
4. Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study. Tod M; Minozzi C; Beaucaire G; Ponsonnet D; Cougnard J; Petitjean O J Antimicrob Chemother; 1999 Jul; 44(1):99-108. PubMed ID: 10459816 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics and pharmacodynamics of isepamicin. Tod M; Padoin C; Petitjean O Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic study of isepamicin with intensive care unit patients. Tod M; Padoin C; Minozzi C; Cougnard J; Petitjean O Antimicrob Agents Chemother; 1996 Apr; 40(4):983-7. PubMed ID: 8849264 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients. Horvatits T; Kitzberger R; Drolz A; Zauner C; Jäger W; Böhmdorfer M; Kraff S; Fritsch A; Thalhammer F; Fuhrmann V; Schenk P Antimicrob Agents Chemother; 2014; 58(1):94-101. PubMed ID: 24145543 [TBL] [Abstract][Full Text] [Related]
11. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients. Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients. Guenter SG; Iven H; Boos C; Bruch HP; Muhl E Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556 [TBL] [Abstract][Full Text] [Related]